Schonfeld Strategic Advisors »

Anika Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $160k 11k 14.50
2020-09-30 $350k 9.9k 35.33
2020-03-31 $301k 10k 28.88
2018-06-30 $361k 11k 31.95

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Kraneshares Trust Csi Chi Internet (KWEB)
CRH Ord (CRH)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ishares Tr China Lg-cap Etf (FXI)
Palantir Technologies Cl A (PLTR)
Unity Software (U)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Schonfeld Strategic Advisors

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Morgan Stanley
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Boothbay Fund Management
Renaissance Technologies
Dimensional Fund Advisors
Capital Management Corporation
Deutsche Bank Aktiengesellschaft
State Street Corporation
Geode Capital Management
AQR Capital Management
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics